Verbeuren T J, Laekeman G, Majchrowicz B B, Jordaens F H, Zonnekeyn L L, Herman A G
J Pharmacol Exp Ther. 1985 Jun;233(3):801-9.
The effects of tertatolol, a new and powerful beta adrenoceptor blocking drug, on post- and prejunctional beta receptors were investigated; canine vascular tissues (saphenous veins, coronary arteries and splenic arteries) and guinea-pig trachea and atria were used. At concentrations below 10(-5) M, tertatolol did not alter basal tension or contractile responses to electrical stimulation, norepinephrine, K+ or prostaglandin F2 alpha; at doses at or above 10(-5) M the drug-evoked contractions which were reduced by phentolamine and were absent in denervated veins. Tertatolol at 10(-5) M and 3 X 10(-5) M augmented the basal efflux of [3H] norepinephrine in saphenous veins labeled with the 3H-transmitter. In veins, 10(-5) M of tertatolol depressed the contractions caused by electrical stimulation without affecting those to exogenous norepinephrine; this concentration of the drug also inhibited the stimulation-induced overflow of [3H]norepinephrine. The major part of the present study was designed to test the beta receptor blocking properties of tertatolol and to compare its effects with those of propranolol. Tertatolol inhibited, in a concentration-dependent manner, the relaxations caused by isoproterenol in saphenous veins, splenic arteries and coronary arteries and the relaxations evoked by norepinephrine and epinephrine in coronary arteries; the potency of tertatolol was higher than that of propranolol. In trachea and right atria of the guinea-pig, tertatolol inhibited, in a concentration-dependent manner, the dose-response curves to isoproterenol; the relative potency of tertatolol was higher than that of propranolol. In dog saphenous veins, previously incubated with [3H]norepinephrine, tertatolol (10(-7)M) blocked the increased stimulation-evoked overflow of the 3H-transmitter induced by isoproterenol.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了新型强效β肾上腺素受体阻断药替他洛尔对节后和节前β受体的作用;使用了犬血管组织(大隐静脉、冠状动脉和脾动脉)以及豚鼠气管和心房。在浓度低于10^(-5) M时,替他洛尔不改变基础张力或对电刺激、去甲肾上腺素、K⁺或前列腺素F2α的收缩反应;在剂量等于或高于10^(-5) M时,该药物引起的收缩可被酚妥拉明减弱,且在去神经的静脉中不存在。10^(-5) M和3×10^(-5) M的替他洛尔增加了用³H递质标记的大隐静脉中[³H]去甲肾上腺素的基础流出量。在静脉中,10^(-5) M的替他洛尔抑制电刺激引起的收缩,但不影响对外源性去甲肾上腺素的收缩;该药物浓度也抑制刺激诱导的[³H]去甲肾上腺素溢出。本研究的主要部分旨在测试替他洛尔的β受体阻断特性,并将其作用与普萘洛尔的作用进行比较。替他洛尔以浓度依赖的方式抑制异丙肾上腺素在大隐静脉、脾动脉和冠状动脉中引起的舒张以及去甲肾上腺素和肾上腺素在冠状动脉中引起的舒张;替他洛尔的效力高于普萘洛尔。在豚鼠气管和右心房中,替他洛尔以浓度依赖的方式抑制对异丙肾上腺素的剂量反应曲线;替他洛尔的相对效力高于普萘洛尔。在预先用[³H]去甲肾上腺素孵育的犬大隐静脉中,替他洛尔(10^(-7)M)阻断了异丙肾上腺素诱导的刺激诱发的³H递质溢出增加。(摘要截短于250字)